When was FivePrime Therapeutics founded?

FivePrime Therapeutics was founded in 2001.

Where is FivePrime Therapeutics headquartered?

FivePrime Therapeutics is headquartered in South San Francisco, California, United States.

What industry is FivePrime Therapeutics in?

FivePrime Therapeutics operates in Biotech, Healthcare.

How many employees does FivePrime Therapeutics have?

FivePrime Therapeutics has 51-200 employees.

FivePrime Therapeutics

IPO

South San Francisco, United States · Founded 2001

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2001

Business Model: B2B
Website: fiveprime.com

About

Five Prime Therapeutics was a clinical-stage biopharmaceutical company founded in 2001 in South San Francisco, California, focused on discovering and developing innovative protein and antibody drugs to treat cancer and inflammatory diseases. The company's lead drug candidate, bemarituzumab, targeted a mutant form of fibroblast growth factor receptor (FGFR2b) implicated in certain cancers. Five Prime Therapeutics was publicly traded on NASDAQ (FPRX) until its acquisition by Amgen in April 2021 for approximately $1.9 billion in cash.

Summary

FivePrime Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2001.